These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28032980)

  • 1. Ligand Discovery for a Peptide-Binding GPCR by Structure-Based Screening of Fragment- and Lead-Like Chemical Libraries.
    Ranganathan A; Heine P; Rudling A; Plückthun A; Kummer L; Carlsson J
    ACS Chem Biol; 2017 Mar; 12(3):735-745. PubMed ID: 28032980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.
    Kampen S; Rodríguez D; Jørgensen M; Kruszyk-Kujawa M; Huang X; Collins M; Boyle N; Maurel D; Rudling A; Lebon G; Carlsson J
    ACS Chem Biol; 2022 Oct; 17(10):2744-2752. PubMed ID: 36149353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures.
    Rodríguez D; Ranganathan A; Carlsson J
    Curr Top Med Chem; 2015; 15(24):2484-503. PubMed ID: 26126906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment screening by SPR and advanced application to GPCRs.
    Shepherd CA; Hopkins AL; Navratilova I
    Prog Biophys Mol Biol; 2014; 116(2-3):113-23. PubMed ID: 25301577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking Finds GPCR Ligands in Dark Chemical Matter.
    Ballante F; Rudling A; Zeifman A; Luttens A; Vo DD; Irwin JJ; Kihlberg J; Brea J; Loza MI; Carlsson J
    J Med Chem; 2020 Jan; 63(2):613-620. PubMed ID: 31846328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.
    Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J
    J Med Chem; 2017 Oct; 60(19):8160-8169. PubMed ID: 28929756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands.
    Huber S; Casagrande F; Hug MN; Wang L; Heine P; Kummer L; Plückthun A; Hennig M
    PLoS One; 2017; 12(5):e0175842. PubMed ID: 28510609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in the fragment-based drug discovery].
    Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK
    Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based discovery of A2A adenosine receptor ligands.
    Carlsson J; Yoo L; Gao ZG; Irwin JJ; Shoichet BK; Jacobson KA
    J Med Chem; 2010 May; 53(9):3748-55. PubMed ID: 20405927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface plasmon resonance analysis of seven-transmembrane receptors.
    Aristotelous T; Hopkins AL; Navratilova I
    Methods Enzymol; 2015; 556():499-525. PubMed ID: 25857797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based discovery of beta2-adrenergic receptor ligands.
    Kolb P; Rosenbaum DM; Irwin JJ; Fung JJ; Kobilka BK; Shoichet BK
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6843-8. PubMed ID: 19342484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPCR-Based Bioactive Peptide Screening Using Phage-Displayed Peptides and an Insect Cell System for Insecticide Discovery.
    Choi MY; Vander Meer RK
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33923387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemogenomics approaches to G-protein coupled receptor lead finding.
    Klabunde T; Jäger R
    Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G Protein-Coupled Receptors - Targets for Fragment-based Drug Discovery.
    Lawson AD
    Curr Top Med Chem; 2015; 15(24):2523-7. PubMed ID: 26126904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.